Passage BIO, Inc. - PASG

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$15.31M
QoQ value delta ($000)
-$3.292M (-17.7%)
Implied price effect (QoQ)
-31.91%
Shares
Total shares
1,906,693
QoQ shares delta
+329,279 (+20.87%)
Total shares held by funds (by quarter)

Market chart (PASG)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 35 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Lynx1 Capital Management LP 4,896 623,704 0.77%
Vestal Point Capital, LP 2,394 305,000 0.07%
VANGUARD GROUP INC 1,494 126,645 0.0%
RENAISSANCE TECHNOLOGIES LLC 1,048 133,612 0.0%
Eversept Partners, LP 1,032 131,581 0.05%
VANGUARD CAPITAL MANAGEMENT LLC 894 113,964 0.0%
Yiheng Capital Management, L.P. 675 86,097 0.29%
Ikarian Capital, LLC 534 68,124 0.04%
Erste Asset Management GmbH 526 85,262 0.0%
GEODE CAPITAL MANAGEMENT, LLC 324 41,380 0.0%
BlackRock, Inc. 224 28,595 0.0%
UBS Group AG 215 27,501 0.0%
ACADIAN ASSET MANAGEMENT LLC 189 24,196 0.0%
Verdad Advisers, LP 173 22,128 0.19%
DIADEMA PARTNERS LP 153 19,530 0.03%
BOOTHBAY FUND MANAGEMENT, LLC 148 18,871 0.0%
VANGUARD FIDUCIARY TRUST CO 133 17,049 0.0%
XTX Topco Ltd 99 12,627 0.0%
FIDUCIARY TRUST CO 84 10,750 0.0%
Persistent Asset Partners Ltd 38 4,955 0.01%
MORGAN STANLEY 20 2,650 0.0%
Rockefeller Capital Management L.P. 6 800 0.0%
Vanguard Global Advisers, LLC 5 638 0.0%
Tower Research Capital LLC (TRC) 3 502 0.0%
BARCLAYS PLC 1 212 0.0%